Renaissance Capital logo

Abcam Priced, Nasdaq: ABCM

Sells biological reagents and tools for research, drug discovery, and diagnostics.

Industry: Health Care

Latest Trade: $22.66 0.00 (0.0%)

First Day Return: +12.9%

Return from IPO: +29.5%

Industry: Health Care

We are a global life science company focused on identifying, developing and distributing high-quality reagents and tools for our customers at the forefront of life science research. Our products are used by researchers to study biological pathways, which is critical for scientific research, diagnostics and drug discovery. Our mission is to provide life science researchers with highly validated products and services to advance biological research and achieve their goals faster. We do this by continuously innovating and providing our customers with high-quality tools, together with expert customer support. Our product offering includes an extensive portfolio of antibodies and related protein research tools that are fundamental to our customers’ research and experimental workflow. Our customers are primarily scientists and researchers in academic institutions, research institutes and pharmaceutical, biotechnology and diagnostics companies. Headquartered in Cambridge, United Kingdom, we operate across 15 locations around the world, supported by our world-class team of approximately 1,500 employees, including over 200 with PhDs, and have served customers in over 130 countries.
more less
IPO News for Abcam
more
IPO Data
IPO File Date 10/02/2020
Offer Price $17.50
Price Range $17.50 - $17.50
Offer Shares (mm) 8.9
Deal Size ($mm) $157
Lock-Up Date IPO Pro Only
Street Research IPO Pro Only
IPO Data
IPO Date 10/21/2020
Offer Price $17.50
Price Range $17.50 - $17.50
Offer Shares (mm) 8.9
Deal Size ($mm) $157
Lock-Up Date IPO Pro Only
Street Research IPO Pro Only
Underwriters
more
Company Data
Headquarters Cambridge, United Kingdom
Founded 1998
Employees 1,492
Website www.abcamplc.com